← All companies

CTXR

Citius Pharmaceuticals, Inc.

CTXR Nasdaq Pharmaceutical Preparations EDGAR ↗

$0.60

-0.04 -5.70%

Key statistics

from XBRL data in SEC filings

Market cap

$16.4M

Revenue (TTM)

$90.0K

Net income (TTM)

-$55.5M

EPS (TTM)

$-2.14

P/E ratio

—

Dividend yield

100.67%

Free cash flow

-$26.6M

Cash

$4.59M

Total assets

$133M

Gross margin

—

52-week range

$0.47 – $2.19

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Other events Jun 1, 2026 8-K Results of operations (earnings release) May 15, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Entered a material agreement May 8, 2026 8-K Unregistered sale of equity; Other events Apr 29, 2026 8-K Entered a material agreement; Other events Apr 24, 2026 8-K Shareholder vote results Apr 6, 2026 8-K Other events Mar 31, 2026 8-K Other events Mar 10, 2026 8-K Other events Mar 4, 2026 8-K Results of operations (earnings release); Delisting notice or listing-rule failure Feb 13, 2026 10-Q Quarter ended 2025-12-31 Feb 13, 2026 10-K/A Fiscal year ended 2025-09-30 Jan 28, 2026 8-K Results of operations (earnings release) Dec 23, 2025 10-K Fiscal year ended 2025-09-30 Dec 23, 2025 8-K Regulation FD disclosure; Other events Dec 1, 2025 8-K Regulation FD disclosure Oct 23, 2025 8-K Entered a material agreement; Other events Oct 21, 2025 8-K Results of operations (earnings release) Aug 12, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Other events Jul 8, 2025 8-K Entered a material agreement; Other events Jun 12, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Shareholder vote results Jun 9, 2025 8-K Entered a material agreement; Took on a direct financial obligation Jun 3, 2025 8-K Delisting notice or listing-rule failure May 30, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 14, 2025 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws Apr 18, 2025 8-K Entered a material agreement Apr 3, 2025 8-K Entered a material agreement; Other events Apr 2, 2025 8-K Shareholder vote results Mar 10, 2025 8-K Other events Feb 14, 2025 10-Q Quarter ended 2024-12-31 Feb 14, 2025 8-K Other events Feb 6, 2025 10-K/A Fiscal year ended 2024-09-30 Jan 27, 2025 8-K Entered a material agreement; Other events Jan 8, 2025 8-K Other events Jan 7, 2025 8-K Results of operations (earnings release) Dec 27, 2024 10-K Fiscal year ended 2024-09-30 Dec 27, 2024 8-K Other events Dec 20, 2024